Approximately 10 percent of pancreatic ductal adenocarcinoma is due to a hereditary or genetic predisposition, including variants in the breast and ovarian cancer syndrome genes BRCA1 and BRCA2. The Mount Sinai Health System is building a comprehensive surveillance program aimed at early detection and risk stratification of individuals whose genes may put them at increased risk of pancreatic cancer.